Answers are grounded in this paper and cite their sources.
This study evaluated the Cutaneous Lupus Erythematosus (CLE) Quality of Life index (CLEQoL) as a valid, accurate, and longitudinally responsive patient reported outcome measure amongst CLE patients. Results show that the CLEQoL accurately captures QoL impacts amongst CLE patients and tracks changes in QoL impacts across time and disease activity.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: